Neural correlates of social cognitive deficits in schizophrenia patients with and without cannabis use

How to better understand the neurocognitive and social cognitive dysfunction in individuals with substance use disorders and co-morbid psychiatric illness

There is evidence of an association between regular cannabis use and psychotic symptoms disorders, both in general population and in individual with schizophrenia. Although studies have shown a link, the relation between cannabinoid use and psychosis is still under review.

As an Assistant Professor in the Department of Psychiatry and a researcher at the Douglas Research Centre, Dr. Rachel Rabin is currently working together with her research group to examine the effects of chronic cannabis use on social cognition and underlying brain structure. 

The aim of this study is to help identify therapeutic targets to improve treatments for individuals suffering from schizophrenia and/or cannabis addictions.

Funded through HBHL’s New Recruit Start-Up Supplements Program, which provides faculties with additional start-up funding to attract outstanding new faculty recruits to McGill, Dr. Rabin is using a combination of neuroimaging approach, such as MRI and EEG, to characterize the underlying structural and functional mechanisms associated with these impaired processes.

Watch the full interview with Dr. Rachel Rabin:

Back to top